1.
2.
Nat Biotechnol
; 40(10): 1427, 2022 10.
Article
in English
| MEDLINE
| ID: mdl-36207596
3.
Nat Biotechnol
; 37(7): 714-721, 2019 07.
Article
in English
| MEDLINE
| ID: mdl-31227821
Subject(s)
Biotechnology/economics , Biotechnology/trends , Drug Industry/economics , Financing, Government/trends , Public Sector/economics , Drug Approval/economics , Drug Approval/statistics & numerical data , Drug Development/economics , Drug Development/trends , Humans , Income/statistics & numerical data , Legislation, Drug , Public Sector/trends
4.
5.
6.
Nat Biotechnol
; 34(7): 709-15, 2016 07 12.
Article
in English
| MEDLINE
| ID: mdl-27404879
7.
8.
Nat Biotechnol
; 33(7): 703-9, 2015 Jul.
Article
in English
| MEDLINE
| ID: mdl-26154007
9.
Nat Biotechnol
; 32(7): 626-32, 2014 Jul.
Article
in English
| MEDLINE
| ID: mdl-25004227
10.
Nat Biotechnol
; 30(8): 751-7, 2012 Aug.
Article
in English
| MEDLINE
| ID: mdl-22871710
11.
Nat Biotechnol
; 29(7): 585-91, 2011 Jul 11.
Article
in English
| MEDLINE
| ID: mdl-21747381
Subject(s)
Biotechnology/economics , Biotechnology/statistics & numerical data , Industry/economics , Industry/statistics & numerical data , Investments/economics , Public Sector/economics , Public Sector/statistics & numerical data , Internationality , Investments/statistics & numerical data , United States
12.
Nat Biotechnol
; 28(8): 793-9, 2010 Aug.
Article
in English
| MEDLINE
| ID: mdl-20697401
Subject(s)
Biotechnology , Drug Industry , Public Sector , Biotechnology/economics , Biotechnology/statistics & numerical data , Biotechnology/trends , Capital Financing/economics , Capital Financing/statistics & numerical data , Drug Industry/economics , Drug Industry/statistics & numerical data , Drug Industry/trends , Humans , Income/statistics & numerical data , Pharmaceutical Preparations/economics , Public Sector/economics , Public Sector/statistics & numerical data , Public Sector/trends , Research
13.
Nat Biotechnol
; 27(8): 710-21, 2009 Aug.
Article
in English
| MEDLINE
| ID: mdl-19668175
ABSTRACT
The sour global economy has left many small public firms gasping for air.
Subject(s)
Biotechnology/economics , Public Sector/economics , Commerce/economics , Cooperative Behavior , Drug Industry/economics , Geography , Licensure , Marketing/economics , Research/economics
14.
Nat Biotechnol
; 26(7): 753-62, 2008 Jul.
Article
in English
| MEDLINE
| ID: mdl-18612294
ABSTRACT
Record profits and financing in the public biotech sector may be unsustainable in the coming years as economies falter.
Subject(s)
Biotechnology/economics , Biotechnology/statistics & numerical data , Capital Financing/economics , Income/statistics & numerical data , Private Sector/economics , Private Sector/statistics & numerical data , Capital Financing/statistics & numerical data , Internationality
15.
Nat Biotechnol
; 25(7): 729-37, 2007 Jul.
Article
in English
| MEDLINE
| ID: mdl-17621294
Subject(s)
Biotechnology/statistics & numerical data , Budgets , Commerce/statistics & numerical data , Income/statistics & numerical data , Industry/statistics & numerical data , Public Sector/economics , Public Sector/statistics & numerical data , Research/economics , Biotechnology/economics , Biotechnology/trends , Europe , Income/trends , Industry/economics , Industry/trends , United States
16.
Nat Biotechnol
; 24(6): 625-34, 2006 Jun.
Article
in English
| MEDLINE
| ID: mdl-16763588
ABSTRACT
Although investors remained cautious of public biotech companies in 2005, acquisitions and research partnerships were on the up.
Subject(s)
Biotechnology/economics , Biotechnology/statistics & numerical data , Income/statistics & numerical data , Industry/economics , Industry/statistics & numerical data , Public Sector/economics , Public Sector/statistics & numerical data , Biotechnology/trends , Europe , Income/trends , Industry/trends , United States
17.
Nat Biotechnol
; 23(6): 663-71, 2005 Jun.
Article
in English
| MEDLINE
| ID: mdl-15940232
18.
Nat Biotechnol
; 22(6): 665-70, 2004 Jun.
Article
in English
| MEDLINE
| ID: mdl-15175683
Subject(s)
Biotechnology/economics , Private Sector/economics , Biotechnology/statistics & numerical data , Biotechnology/trends , Income/statistics & numerical data , Industry/economics , Industry/statistics & numerical data , Industry/trends , Investments/trends , Private Sector/statistics & numerical data , Private Sector/trends , Research/economics , Research/statistics & numerical data
19.
Nat Biotechnol
; 21(6): 607-12, 2003 Jun.
Article
in English
| MEDLINE
| ID: mdl-12776143
Subject(s)
Biotechnology/economics , Biotechnology/statistics & numerical data , Industry/economics , Private Sector , Research/statistics & numerical data , Biotechnology/trends , Commerce/statistics & numerical data , Data Collection/methods , Forecasting , Income/statistics & numerical data , Income/trends , Industry/statistics & numerical data , Investments , United States
20.
Nature
; 420(6916 Suppl): A34-5, A37, A39, 2002 Dec 12.
Article
in English
| MEDLINE
| ID: mdl-12501125
